🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
Immunothrombosis has recently been used to describe the responses/mechanism...
Status
Completed
Location
the Affiliated Hospital of Qingdao University
Start Date
2013-01-01
Trial ID
NCT05541562
Treatments Being Tested
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2019-05-20
Trial ID
NCT03524261
Treatments Being Tested
The purpose is to demonstrate that vasoreactivity of patients with septic s...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT02885168
Treatments Being Tested
Antiretroviral therapy or ART blocks HIV replication reducing plasma viral ...
Status
Recruiting
Location
Unity Health Toronto -St. Michael's Hospital
Start Date
2025-01-14
Trial ID
NCT06823596
Treatments Being Tested
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Biological treatment center in Fuda cancer hospital
Start Date
2018-03-25
Trial ID
NCT03484962
Treatments Being Tested
Paracetamol (PCM) is a widely used over-the-counter analgesic, and overdose...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-08
Trial ID
NCT03679442
Treatments Being Tested
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-12
Trial ID
NCT03509298
Treatments Being Tested
Infections represent the first cause of death and of morbidity in people tr...
Status
Completed
Location
Service de Médecine Interne - CH d'Agen
Start Date
2016-02-16
Trial ID
NCT02280902
Treatments Being Tested